Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03568539
Title IBI308 in Subjects With Advanced/Metastatic Solid Malignancies
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Innovent Biologics (Suzhou) Co. Ltd.
Indications

urinary bladder cancer

prostate cancer

colorectal cancer

melanoma

stomach cancer

endometrial cancer

lung non-small cell carcinoma

lung small cell carcinoma

Therapies

Sintilimab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.